Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Therapeutic approaches targeting prostate cancer progression using novel voltage-gated ion channel blockers.

Sikes RA, Walls AM, Brennen WN, Anderson JD, Choudhury-Mukherjee I, Schenck HA, Brown ML.

Clin Prostate Cancer. 2003 Dec;2(3):181-7. Review.

PMID:
15040863
2.

Design, synthesis and evaluation of novel hydroxyamides as orally available anticonvulsants.

Schenck HA, Lenkowski PW, Choudhury-Mukherjee I, Ko SH, Stables JP, Patel MK, Brown ML.

Bioorg Med Chem. 2004 Mar 1;12(5):979-93.

PMID:
14980611
3.

Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3.

Anderson JD, Hansen TP, Lenkowski PW, Walls AM, Choudhury IM, Schenck HA, Friehling M, Höll GM, Patel MK, Sikes RA, Brown ML.

Mol Cancer Ther. 2003 Nov;2(11):1149-54.

4.

Design, synthesis, and evaluation of analogues of 3,3,3-trifluoro-2-hydroxy-2-phenyl-propionamide as orally available general anesthetics.

Choudhury-Mukherjee I, Schenck HA, Cechova S, Pajewski TN, Kapur J, Ellena J, Cafiso DS, Brown ML.

J Med Chem. 2003 Jun 5;46(12):2494-501.

PMID:
12773053

Supplemental Content

Loading ...
Support Center